Related Experiment Video
Updated: Jul 20, 2026
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Current and novel approaches to the drug therapy of obesity
Jean-Philippe Chaput1, Angelo Tremblay
1Division of Kinesiology, Department of Social and Preventive Medicine, Faculty of Medicine, Laval University, Ste-Foy, Québec, G1K 7P4, Canada.
Introduction:
Obesity has been described as the greatest current threat to human health. Although diet and lifestyle changes remain the cornerstones of therapy for obesity, weight losses are often small, and long-term success is disappointing.
Discussion:
When these lifestyle-modifying attempts fail, the use of anti-obesity drugs is warranted. Drug treatment is often indicated, but is somewhat limited by the minimal number of well-tolerated drugs that have proven to have long-term efficacy in maintaining body weight loss. The currently available drugs, sibutramine and orlistat, appear modestly effective in promoting weight loss. However, pharmacological therapy for obesity is in transition; expanding knowledge of the physiological mechanisms of body weight regulation has revealed new molecular targets, and more than 150 novel agents are under active development.
Conclusions:
Because weight regulation is complex, and redundant systems protect against perceived starvation, optimal treatment of obesity will likely require combinations of therapies. In addition, a better comprehension of the problem prior to its treatment would be preferable before targeting homeostatic pathways which could be irrelevant.
Insights
Anti-obesity drugs offer a solution when lifestyle changes fail, but current options have limitations. Future pharmacological therapies for obesity are evolving with new molecular targets and combination approaches.
Area of Science:
- Obesity research
- Pharmacological interventions
- Human health
Background:
- Obesity is a major global health threat.
- Diet and lifestyle changes are primary obesity treatments but yield limited long-term success.
- Pharmacological interventions are considered when lifestyle modifications are insufficient.
Purpose of the Study:
- To review the current status and future directions of anti-obesity drug therapy.
- To highlight the limitations of existing anti-obesity medications.
- To discuss the evolving landscape of pharmacological treatments for obesity.
Main Methods:
- Review of current literature on obesity and anti-obesity drugs.
- Analysis of the efficacy and tolerability of existing medications (sibutramine, orlistat).
- Exploration of emerging molecular targets and novel agents in obesity drug development.
Main Results:
- Current anti-obesity drugs (sibutramine, orlistat) show modest efficacy in weight loss.
- The field of obesity pharmacotherapy is undergoing significant transition.
- Over 150 novel anti-obesity agents targeting new molecular pathways are in development.
Conclusions:
- Anti-obesity drug treatment is warranted for individuals unresponsive to lifestyle changes.
- Optimal obesity management may require combination therapies due to complex weight regulation.
- Further understanding of obesity's physiological mechanisms is crucial for developing more effective treatments.
Related Concept Videos
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
01:21Drug Dosing: Obese Patients
01:28Drug Therapy
Antianxiety Medications
01:23Antidepressant Drugs: MAOIs and Other Agents
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
01:15Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...